Arizona MPJE (Pharmacy Jurisprudence) Practice Exam

Question: 1 / 400

A drug offered for sale under the name of another drug is termed:

Adulterated

Branded

Misbranded

When a drug is offered for sale under the name of another drug, it is classified as misbranded. Misbranding occurs when the labeling of a product is false or misleading in any way, which includes presenting a drug under a name that is not its own. This misrepresentation can create confusion for consumers and healthcare providers regarding the identity of the medication, which can lead to inappropriate use or dosing.

Adulteration, on the other hand, refers to a product that is contaminated or contains an unsafe substance, affecting its purity and safety. Branded typically refers to drugs that are marketed under a trademarked name, and a recall refers to the withdrawal of a product from the market due to safety issues or violations. Thus, misbranding accurately captures the issue of offering a drug under another drug's name, as it directly relates to misleading information about the product's identity.

Ask an Examzify Tutor

Recalled

Next Question

Report this question

Download Arizona MPJE (Pharmacy Jurisprudence) Practice Exam PDF Study Guide
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy